Luke Maese
Impact in
-
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- Childhood Cancer Survivors' Quality of Life
Papers in
- Oncology 19
- Cancer-related Molecular Pathways 8
-
- Acute Lymphoblastic Leukemia research 16
- Co-authors
- Rachel E. Rau (10 shared papers)Elizabeth A. Raetz (11 shared papers)Wendy Kohlmann (9 shared papers)Anupam Verma (1 shared paper)Sarah K. Tasian (1 shared paper)Joshua D. Schiffman (8 shared papers)Kim E. Nichols (4 shared papers)Carmelo Rizzari (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Blood (7 papers)Pediatric Blood & Cancer (4 papers)JCO Precision Oncology (4 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Luke Maese
41 papers receiving 359 citations
Peers
Comparison fields: 5 of 54
- Hematology 58
- Pediatrics, Perinatology and Child Health 95
- Public Health, Environmental and Occupational Health 138
- Speech and Hearing 28
- Oncology 102
Countries citing papers authored by Luke Maese
This map shows the geographic impact of Luke Maese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Maese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Maese more than expected).
Fields of papers citing papers by Luke Maese
This network shows the impact of papers produced by Luke Maese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Maese. The network helps show where Luke Maese may publish in the future.
Co-authors
The 25 scholars most cited alongside Luke Maese, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 45 | |
| 2 | 2019 | 41 | |
| 3 | 2020 | 31 | |
| 4 | 2021 | 26 | |
| 5 | 2019 | 24 | |
| 6 | 2021 | 22 | |
| 7 | 2019 | 20 | |
| 8 | 2017 | 18 | |
| 9 | 2022 | 18 | |
| 10 | 2020 | 17 | |
| 11 | 2016 | 15 | |
| 12 | 2024 | 8 | |
| 13 | 2021 | 6 | |
| 14 | 2019 | 6 | |
| 15 | 2020 | 6 | |
| 16 | 2020 | 6 | |
| 17 | 2022 | 5 | |
| 18 | 2020 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2023 | 4 |
About Luke Maese
Luke Maese is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 49 papers that have together received 366 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (16 papers), Childhood Cancer Survivors' Quality of Life (13 papers), Cancer-related Molecular Pathways (8 papers), Cancer Genomics and Diagnostics (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Acute Myeloid Leukemia Research (4 papers), Neuroblastoma Research and Treatments (4 papers) and Transgenic Plants and Applications (4 papers). The work is most often cited by research in Hematology (58 citations), Pediatrics, Perinatology and Child Health (95 citations), Public Health, Environmental and Occupational Health (138 citations), Speech and Hearing (28 citations) and Oncology (102 citations). Luke Maese has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Rachel E. Rau, Elizabeth A. Raetz, Wendy Kohlmann, Anupam Verma, Sarah K. Tasian, Joshua D. Schiffman, Kim E. Nichols, Carmelo Rizzari, Christopher C. Porter and Inge M. van der Sluis. Their work appears in journals such as Journal of Clinical Oncology, Blood, Pediatric Blood & Cancer, JCO Precision Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.